Ursodeoxycholic acid therapy in pregnant women with cholestasis

International Journal of Gynecology and Obstetrics

Volumn 52, Issue 2, 1996, Pages 133-140

  Diaferia, A ^a   Nicastri, P L ^a,c   Tartagni, M ^a   Loizzi, P ^a   Iacovizzi, C ^a   Di Leo, A ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^c NONE   (Italy)

Author keywords

Bile salts; Intrahepatic cholestasis of pregnancy; Pruritus

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILE SALT; BILIRUBIN; BILIRUBIN GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE; URSODEOXYCHOLIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER FUNCTION TEST; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

EID: 0030050836     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-7292(95)02528-6     Document Type: Article

References (25)

1. Berg B, Helm G, Petersohn L et al. Cholestasis of pregnancy: clinical and laboratory studies. Acta Obstet Gynecol Scand 1986; 65: 107.
2. Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy. Obstet Gynecol 1991; 98: 540.
3. Holzback RT, Sivak DA, Braum WE. Familiar recurrent intrahepatic cholestasis of pregnancy: a genetic study providing evidence for transmission of a sex-limited dominant trait. Gastroenterology 1983; 85: 175.
4. Kreek MJ, Sleinger MH et al. Recurrent cholestasis jaundice of pregnancy with demonstrated estrogen sensitivity. Am J Med 1967; 43: 795.
5. Schreiber AJ, Simon FR. Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology 1983; 3: 607.
6. Reyes H, Radrigàn ME, Gonzales MC, Latone R, Ribalta J, Segovia N et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Gastroenterology 1987; 93: 584.
7. Samuelson K, Thomassen PA. Radioimmunoassay of serum bile acids in normal pregnancy and in recurrent cholestasis of pregnancy. Acta Obstet Gynecol Scand 1980; 59: 417.
8. Carter J. Serum bile acids in normal pregnancy. Br J Obstet Gynaecol 1991; 98: 540.
9. Laatikanen T, Tulenheima A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynecol Obstet 1984; 22: 91.
10. Lunzer M, Barnes P, Byth K et al. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. Gastroenterology 1986; 91: 825.
11. Laatikassen T, Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol 1977; 50: 313.
12. Heikinnen J, Maentauste O, Ylostalo P et al. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol 1981; 88: 240.
13. Reyd R, Ivey KJ, Recent RH. Fetal complication of obstetric cholestasis. Br Med J 1976; 1: 870.
14. Fisk NM, Storey GNB. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988; 95: 1137.
15. James OFW. Ursodeoxycholic acid treatment for chronic cholestatic liver disease. J Hepatol 1990; 11: 5.
16. Podola M, Ghezzi C, Battezzati PM, Crossignani A, Zuin M, Roda A. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology 1990; 98: 1044.
17. Leuschner U, Fischer H, Kurtz W, Guldutuna S, Hubner K, Hellstern A et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989; 97: 1269.
18. O'Brien C, Senior JR, Batta AK, Arara R, Tint GS, Salen G. Ursodeoxycholic acid treatment produces marked clinical and biochemical amelioration of primary sclerosing cholangitis (abstract). Gastroenterology 1989; 96: 640.
19. Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990; 11: 12.
20. Palma J, Reyes H, Ribalta J, Iglesias J et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992; 15: 1043.
21. Crossignani A, Podola M, Bertolini E, Battezzati PM, Zuin M, Setchell DKR. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent cholestasis: a study of bile acid metabolism. Hepatology 1991; 13: 1076.
22. Leuschner U, Kurtz W. Pharmacological aspects and therapeutic effects of ursodeoxycholic acid. Dig Dis Sci 1990; 8: 12.
23. 125I-labeled ligands. Clin Chem 1979; 25: 264.
24. Heikinnen J, Mãentausta O, Tuimala R, Viostalo P, Janne O. Amniotic fluid bile acids in normal and pathologic pregnancy. Obstet Gynecol 1980; 56: 60.
25. Gustefsson J, Anderson S, Sjövell J. Bile acid metabolism during development: metabolism of lithocholic acid in human fetal liver. Pediatr Res 1987; 21: 99.